tirzepatide phase 3 Lilly's Reduced Heart Failure and Obesity Symptoms in Trial Phase 3 randomized controlled clinical

Combining both drugs can also offer better weight loss results

Bidirectional sync (pulling appointment data from the EHR, pushing intake data back) is the standard for modern platforms

Semaglutide is a medication primarily used to manage type 2 diabetes and, more recently, for weight management in individuals with obesity

Accelerates muscle recovery and reduces exercise-induced muscle damage, supporting faster post-workout recovery

Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions

These medications particularly benefit patients with a BMI of 30 or more, who face four to five times higher risk of heart disease, stroke, and diabetes 2